Search research articles
Contact Us
Filters
Showing results (71-80 of 126) with videos related to
Page
of 13
Sort By:
JMA Journal
|
February 10, 2025
Change in Breast Cancer Screening Participation during COVID-19 Based on the 2019 and 2022 Comprehensive Survey of Living Conditions in Japan
Chitose Kawamura, Masao Iwagami, Jun Komiyama, et al.
Breast Cancer (Tokyo, Japan)
|
June 28, 2020
Physician's knowledge, attitudes and practice pattern for breast cancer diagnosed during pregnancy: a survey among breast care specialists in Japan
Hiroko Bando, Akemi Kataoka, Kentaro Tamaki, et al.
Plos One
|
April 7, 2016
Increased Soluble CD155 in the Serum of Cancer Patients
Akiko Iguchi-Manaka, Genki Okumura, Hiroshi Kojima, et al.
Japanese Journal of Clinical Oncology
|
March 1, 2011
Evaluation of trastuzumab without chemotherapy as a post-operative adjuvant therapy in HER2-positive elderly breast cancer patients: randomized controlled trial [RESPECT (N-SAS BC07)]
Masataka Sawaki, Nahomi Tokudome, Toshiro Mizuno, et al.
The Lancet Regional Health. Western Pacific
|
April 10, 2025
Non-cancer risks among female breast cancer survivors: a matched cohort study in Japan
Chitose Kawamura, Krishnan Bhaskaran, Takaaki Konishi, et al.
Anticancer Research
|
August 28, 2025
Paclitaxel-induced Peripheral Neuropathy and Quality of Life: Sub-analysis of the MICHEL Study
Aya Sawa, Riko Sato, Tomohei Matsuo, et al.
Breast Cancer (Tokyo, Japan)
|
August 27, 2025
Risk of endometrial cancer among breast cancer survivors in Japan: a matched cohort study
Chitose Kawamura, Krishnan Bhaskaran, Takaaki Konishi, et al.
Pathology International
|
August 26, 2025
C-Myc Overexpression in Adolescent and Young Adult Breast Cancer: Distinct From Older Adults With Relevantly Expressed Cholecystokinin B Receptor
Tomoyuki Tanino, Yoko Nakanishi, Haruna Nishimaki-Watanabe, et al.
BMJ Open
|
March 3, 2022
Study protocol for a double-blind, comparative, randomised Japanese trial of triplet standard antiemetic therapies with or without 5 mg olanzapine to prevent chemotherapy-induced nausea and vomiting for patients with breast cancer treated with an anthracycline/cyclophosphamide regimen (JTOP-B)
Rie Ozeki, Hirotoshi Iihara, Mototsugu Shimokawa, et al.
Breast Cancer (Tokyo, Japan)
|
February 9, 2019
Pharmacogenomic-pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer
Hiroshi Ishiguro, Shinji Ohno, Yutaka Yamamoto, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 126) with videos related to
Sort By:
Page
of 13
JMA Journal
|
February 10, 2025
Change in Breast Cancer Screening Participation during COVID-19 Based on the 2019 and 2022 Comprehensive Survey of Living Conditions in Japan
Chitose Kawamura, Masao Iwagami, Jun Komiyama, et al.
Breast Cancer (Tokyo, Japan)
|
June 28, 2020
Physician's knowledge, attitudes and practice pattern for breast cancer diagnosed during pregnancy: a survey among breast care specialists in Japan
Hiroko Bando, Akemi Kataoka, Kentaro Tamaki, et al.
Plos One
|
April 7, 2016
Increased Soluble CD155 in the Serum of Cancer Patients
Akiko Iguchi-Manaka, Genki Okumura, Hiroshi Kojima, et al.
Japanese Journal of Clinical Oncology
|
March 1, 2011
Evaluation of trastuzumab without chemotherapy as a post-operative adjuvant therapy in HER2-positive elderly breast cancer patients: randomized controlled trial [RESPECT (N-SAS BC07)]
Masataka Sawaki, Nahomi Tokudome, Toshiro Mizuno, et al.
The Lancet Regional Health. Western Pacific
|
April 10, 2025
Non-cancer risks among female breast cancer survivors: a matched cohort study in Japan
Chitose Kawamura, Krishnan Bhaskaran, Takaaki Konishi, et al.
Anticancer Research
|
August 28, 2025
Paclitaxel-induced Peripheral Neuropathy and Quality of Life: Sub-analysis of the MICHEL Study
Aya Sawa, Riko Sato, Tomohei Matsuo, et al.
Breast Cancer (Tokyo, Japan)
|
August 27, 2025
Risk of endometrial cancer among breast cancer survivors in Japan: a matched cohort study
Chitose Kawamura, Krishnan Bhaskaran, Takaaki Konishi, et al.
Pathology International
|
August 26, 2025
C-Myc Overexpression in Adolescent and Young Adult Breast Cancer: Distinct From Older Adults With Relevantly Expressed Cholecystokinin B Receptor
Tomoyuki Tanino, Yoko Nakanishi, Haruna Nishimaki-Watanabe, et al.
BMJ Open
|
March 3, 2022
Study protocol for a double-blind, comparative, randomised Japanese trial of triplet standard antiemetic therapies with or without 5 mg olanzapine to prevent chemotherapy-induced nausea and vomiting for patients with breast cancer treated with an anthracycline/cyclophosphamide regimen (JTOP-B)
Rie Ozeki, Hirotoshi Iihara, Mototsugu Shimokawa, et al.
Breast Cancer (Tokyo, Japan)
|
February 9, 2019
Pharmacogenomic-pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer
Hiroshi Ishiguro, Shinji Ohno, Yutaka Yamamoto, et al.
Page
of 13